We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+15.08%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
-$122M
Cap. Flow
-$553M
Cap. Flow %
-29.79%
Top 10 Hldgs %
74.46%
Holding
121
New
44
Increased
20
Reduced
8
Closed
32
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$29.6M
2
TIF
Tiffany & Co.
TIF
+$26.6M
3
LPT
Liberty Property Trust
LPT
+$17.2M
4
AGN
Allergan plc
AGN
+$16.2M
5
MDCO
Medicines Co
MDCO
+$13.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$44.7M
2
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$13.8M
3
CBM
Cambrex Corporation
CBM
+$7.14M
4
WBC
WABCO HOLDINGS INC.
WBC
+$7.02M
5
GWR
Genesee & Wyoming Inc.
GWR
+$6.91M

Sector Composition

Rank Sector Weight
1 Miscellaneous 79.37%
2 Healthcare 8.05%
3 Consumer Discretionary 2.94%
4 Technology 2.46%
5 Communication Services 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LBTYK icon
26
Liberty Global Class C
LBTYK
$2.69B
$3.8M 0.21%
174,462
+90,262
+107% +$2.03M
2019 Q3
1 quarter
W icon
27
PUT
Wayfair
W
$15.3B
$3.8M 0.2%
42,000
+20,000
+91% +$1.87M
2019 Q3
1 quarter
CBPX
28
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$3.64M 0.2%
+100,000
New +$3.29M
2019 Q4
0 quarters
BOLD icon
29
DELISTED
Audentes Therapeutics, Inc
BOLD
$3.59M 0.19%
+60,000
New +$2.25M
2019 Q4
0 quarters
BMRN icon
30
PUT
BioMarin Pharmaceuticals
BMRN
$10.8B
$3.47M 0.19%
41,000
+14,000
+52% +$1.06M
2019 Q1
3 quarters
BREW icon
31
DELISTED
Craft Brew Alliance, Inc.
BREW
$3.46M 0.19%
+210,000
New +$2.62M
2019 Q4
0 quarters
HPQ icon
32
HP
HPQ
$27.8B
$3.29M 0.18%
+160,000
New +$3.03M
2019 Q4
0 quarters
WMGI
33
PUT
DELISTED
Wright Medical Group Inc
WMGI
$3.27M 0.18%
107,200
+57,200
+114% +$1.5M
2019 Q3
1 quarter
TDOC icon
34
Teladoc Health
TDOC
$1.08B
$3.25M 0.18%
38,800
+7,800
+25% +$594K
2019 Q3
1 quarter
PACB icon
35
Pacific Biosciences
PACB
$609M
$3.08M 0.17%
600,000
-400,000
-40% -$2.03M
2018 Q4
4 quarters
SIOX
36
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3.07M 0.17%
598,700
+283,000
+90% +$1.57M
2019 Q3
1 quarter
DRRX icon
37
CALL
DELISTED
DURECT Corp
DRRX
$2.6M 0.14%
+68,480
New +$1.41M
2019 Q4
0 quarters
RARX
38
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.35M 0.13%
+50,000
New +$2.21M
2019 Q4
0 quarters
UA icon
39
Under Armour Class C
UA
$2.04B
$2.29M 0.12%
119,607
-60,493
-34% -$1.06M
2019 Q1
3 quarters
THOR icon
40
CALL
DELISTED
Synthorx, Inc. Common Stock
THOR
$2.29M 0.12%
+32,800
New +$937K
2019 Q4
0 quarters
X icon
41
PUT
DELISTED
US Steel
X
$2.23M 0.12%
+195,000
New +$2.42M
2019 Q4
0 quarters
APLS icon
42
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$2.14M 0.12%
+70,000
New +$1.94M
2019 Q4
0 quarters
BKNG icon
43
PUT
Booking.com
BKNG
$125B
$2.05M 0.11%
25,000
– –
2019 Q1
3 quarters
AVX
44
DELISTED
AVX Corporation
AVX
$2.05M 0.11%
+100,000
New +$1.72M
2019 Q4
0 quarters
APLS icon
45
DELISTED
Apellis Pharmaceuticals
APLS
$2.04M 0.11%
+66,800
New +$1.85M
2019 Q4
0 quarters
TVTX icon
46
PUT
Travere Therapeutics
TVTX
$4.98B
$2.01M 0.11%
141,500
-415,600
-75% -$5.31M
2019 Q1
3 quarters
ICPT
47
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.98M 0.11%
+16,000
New +$1.43M
2019 Q4
0 quarters
ON icon
48
ON Semiconductor
ON
$28.7B
$1.95M 0.1%
79,800
+34,900
+78% +$737K
2019 Q3
1 quarter
BMRN icon
49
BioMarin Pharmaceuticals
BMRN
$10.8B
$1.95M 0.1%
23,000
+200
+0.9% +$15.1K
2018 Q4
4 quarters
BMRN icon
50
CALL
BioMarin Pharmaceuticals
BMRN
$10.8B
$1.86M 0.1%
22,000
+16,000
+267% +$1.21M
2019 Q2
2 quarters
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, DLD Asset Management held 121 positions worth $1.85B, down 6.2% from $1.98B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DLD Asset Management withdrew a net $553M in Q4 2019, closing 32 positions and reducing 8 holdings. Its most notable exit was Celgene Corp, an estimated $44.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 87% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, DLD Asset Management opened a new position in Tech Data Corp worth $33M.

  • DLD Asset Management's largest Q4 2019 buy was Tech Data Corp: 230,000 shares worth $33M.
  • DLD Asset Management added most to Allergan plc in Q4 2019, an estimated $16.2M increase.
  • DLD Asset Management's biggest Q4 2019 reduction was WABCO HOLDINGS INC., cutting an estimated $7.02M.
  • DLD Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $44.7M.
  • DLD Asset Management's ten largest holdings make up 74% of its $1.85B portfolio in Q4 2019.
  • DLD Asset Management opened 44 new positions and closed 32 in Q4 2019.
  • DLD Asset Management's portfolio value fell 6.2% quarter-over-quarter to $1.85B.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.